Evidence brief · Supplement

Fadogia Agrestis for Testosterone (humans)

Evidence grade D — No human trials

Overall grade
Grade D
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade D — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Testosterone (humans)Evidence grade D

    No human trials

    Unclearlow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Testosterone (humans) (grade D).

The evidence in words

The verdict

For testosterone (humans), Fadogia Agrestis earns evidence grade D (unclear effect, low consistency) — the evidence does not support the claim. No human trials

How it might work

Rodent studies suggest it may raise testosterone by stimulating luteinizing hormone signaling — unconfirmed in humans.

How to use it

Not recommended pending human safety and efficacy data.

Safety & cautions

Animal data show organ toxicity; human safety is uncharacterized.

Bottom line

Popular does not mean proven. With no human data and animal toxicity signals, this is one to skip until real research exists.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

n/a
Not recommended.

Goes with

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.